What's Happening?
IQVIA, a global leader in clinical research services, is addressing the increasing operational pressures faced by clinical research sites. As protocols become more complex and technology stacks expand, many sites are expected to deliver more with the same
resources, leading to potential burnout among staff and patients. IQVIA's Kerry Gorman, Head of NA Strategic Site Solutions, discussed in a recent interview the need for a more streamlined, site-centric approach to clinical trials. The company is focusing on site enablement and operational simplification to improve the clinical trial experience. IQVIA is committed to using AI responsibly and employs privacy-enhancing technologies to protect patient data while providing insights to healthcare stakeholders.
Why It's Important?
The operational challenges faced by clinical research sites can significantly impact the efficiency and effectiveness of clinical trials. By simplifying processes and reducing the burden on sites, IQVIA aims to enhance the overall quality of clinical research. This approach could lead to faster development and commercialization of medical treatments, ultimately benefiting patients and healthcare providers. The company's efforts to protect patient privacy while leveraging AI and advanced analytics are crucial in maintaining trust and compliance in the industry.
